Global Endometriosis Market Research Report – Pipeline Review, H2 2017

“The Latest Research Report Endometriosis-Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. – MarketResearchReports.biz”

About Endometriosis Market

Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Endometriosis-Pipeline Review, H2 2017, provides an overview of the Endometriosis (Women’s Health) pipeline landscape.

Endometriosis is an often painful disorder in which tissue that normally lines the inside of uterus (endometrium) grows outside uterus (endometrial implant). Symptoms include pelvic pain, menstrual cramps, inflammation, infertility and abnormal bleeding. Risk factors age, uterine abnormalities, history of pelvic infection and family history. Treatment includes NSAIDs, birth control pills and progestins.

Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1339593

Report Highlights

Global Markets Direct’s Pharmaceutical and Healthcare latest pipeline guide Endometriosis-Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Endometriosis (Women’s Health), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Endometriosis (Women’s Health) pipeline guide also reviews of key players involved in therapeutic development for Endometriosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 2, 9, 7, 1, 14, 5 and 4 respectively. Similarly, the Universities portfolio in Phase II, Preclinical and Discovery stages comprises 1, 4 and 3 molecules, respectively.

Endometriosis (Women’s Health) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

View Sample PDF @ https://www.marketresearchreports.biz/reports/1339593/endometriosis-pipeline-review-h2-2017-market-research-reports.pdf

Scope

– The pipeline guide provides a snapshot of the global therapeutic landscape of Endometriosis (Women’s Health).

– The pipeline guide reviews pipeline therapeutics for Endometriosis (Women’s Health) by companies and universities/research institutes based on information derived from company and industry-specific sources.

– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

– The pipeline guide reviews key companies involved in Endometriosis (Women’s Health) therapeutics and enlists all their major and minor projects.

– The pipeline guide evaluates Endometriosis (Women’s Health) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

– The pipeline guide reviews latest news related to pipeline therapeutics for Endometriosis (Women’s Health)

Reasons to buy

– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

– Find and recognize significant and varied types of therapeutics under development for Endometriosis (Women’s Health).

– Classify potential new clients or partners in the target demographic.

– Develop tactical initiatives by understanding the focus areas of leading companies.

– Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.

– Formulate corrective measures for pipeline projects by understanding Endometriosis (Women’s Health) pipeline depth and focus of Indication therapeutics.

– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

– Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Send An Enquiry Request @ https://www.marketresearchreports.biz/sample/enquiry/1339593

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 5

Introduction 7

Global Markets Direct Report Coverage 7

Endometriosis-Overview 8

Endometriosis-Therapeutics Development 9

Pipeline Overview 9

Pipeline by Companies 10

Pipeline by Universities/Institutes 13

Products under Development by Companies 14

Products under Development by Universities/Institutes 17

Endometriosis-Therapeutics Assessment 18

Assessment by Target 18

Assessment by Mechanism of Action 21

Assessment by Route of Administration 24

Assessment by Molecule Type 26

Endometriosis-Companies Involved in Therapeutics Development 28

AbbVie Inc 28

Addex Therapeutics Ltd 28

APAvadis Biotechnologies Srl 29

Astellas Pharma Inc 29

Bayer AG 30

ElexoPharm GmbH 30

EndoCeutics Inc 31

Enteris BioPharma Inc 31

Evotec AG 32

Forendo Pharma Ltd 32

Kissei Pharmaceutical Co Ltd 33

Lipicard Technologies Ltd 33

Luye Pharma Group Ltd 33

Nippon Shinyaku Co Ltd 34

Ogeda SA 34

Philogen SpA 35

Repros Therapeutics Inc 35

SK Chemicals Co Ltd 35

Takeda Pharmaceutical Co Ltd 36

ValiRx Plc 36

Viramal Ltd 37

Endometriosis-Drug Profiles 38

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket

State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074

Website: http://www.marketresearchreports.biz/

E: sales@marketresearchreports.biz

Leave a Reply

Designed by CyFocus.com
Powered by CyFocus.net